The Latest Articles from Streetwise Reports


News Update

Supplier Enters Canadian Recreational Cannabis Market

News Update
  ()
The Vancouver-based company debuts its premium brand dried flower in Alberta. read more >
News Update

Firm to Launch 3D Augmented Reality Capture App

News Update
  ()
Anyone with the product and a smartphone will be able to create 3D models of 2D objects. read more >

Company Plans Yukon Exploration as Copper Price Predicted to Rise

Contributed Opinion
  ()
Tim Johnson, CEO of Granite Creek Copper, sits down with Maurice Jackson of Proven and Probable to discuss the copper market, his company's exploration plans in the Yukon and its recent purchase of a 30% stake in its neighbor. read more >

Sarepta Shares Get a 35% Boost from FDA Approval of 2nd DMD Drug

  ()
Sarepta Therapeutics shares traded 35% higher after the firm reported that the FDA approved its second RNA exon-skipping treatment drug VYONDYS 53 injection for the treatment of Duchenne's Muscular Dystrophy in patients amenable to skipping Exon 53. read more >

Technical Analyst: Gold's Downtrend Has Further to Run

Contributed Opinion
  ()
Technical analyst Clive Maund looks at recent moves in gold and their correlation to the dollar. read more >

Silver Remains in 'Corrective Downtrend'

Contributed Opinion
  ()
Technical analyst Clive Maund charts the longer term picture for silver. read more >

STACK Agreement 'Positive' for Area Operator

Research Report
  ()
The deal details are relayed in a ROTH Capital Partners report. read more >

Assertio Therapeutics' Shares Jump 50% on Sale of Shingles Pain Drug to Alvogen

  ()
Assertio Therapeutics' shares rose 50% after the firm reported that it has agreed to sell all rights to its Gralise drug used in the treatment of pain from shingles to Alvogen for $127.5 million. The transaction is expected to close in January 2020. read more >

Defense Metals Offers Cheapest Call on Rare Earths and Brilliant Drill Holes

Contributed Opinion
  ()
Bob Moriarty of 321gold looks at the LREO explorer's drill results at its Canadian project. read more >

Proteostasis Therapeutics Reports Positive Results from European Cystic Fibrosis Research

  ()
Proteostasis Therapeutics' shares traded higher after the company reported positive results in its European Cystic Fibrosis study of organoids grown from human stem cells. The firm believes the ongoing ex-vivo study supports initiation of a human clinical trial in mid-2020, and potential for a Marketing Authorization Application in 2021. read more >

Company Signs Earn-in Agreement with MATSA, Eyes Gold Projects

Contributed Opinion
  ()
The Critical Investor sits down with Avrupa Minerals CEO Paul Kuhn to discuss plans for the company's Alvalade project in Portugal in light of the recent earn-in agreement with Mubadala Investment Company and Trafigura. read more >

A.I.S. Resources: A New Gold Prospect + Manganese Trading + Li Extraction Technology

Contributed Opinion
  ()
Peter Epstein of Epstein Research profiles a company that is reinventing itself as moderately diversified battery metals company. read more >
News Update

Royalty Firm to Sell Nevada Asset

News Update
  ()
The consideration for the project is $250,000 in cash and a 2% net smelter return royalty on the claims. read more >
News Update

Recruiter.com Doubles Network Membership Since July

News Update
  ()
The company expects to continue this growth in the near term. read more >
News Update

Augmented Reality Pure Play Lands First Customer in New Vertical

News Update
  ()
This development aligns with the firm's goal of dominating key multibillion dollar business segments. read more >

Oil & Gas Producer Doubles Share Buyback Program to $50 Million, Increases Guidance

Research Report
  ()
Recent company announcements are discussed in a Pareto Securities report. read more >

Coverage Initiated on Mining Triple Threat: Explorer, Developer, Producer

Research Report
  ()
The basis of Haywood's investment thesis for this Canadian company is shared in a recent report. read more >

Petroleum Firm Sells Assets to Focus on Montney Projects

Research Report
  ()
The details, finances and impact of the transaction are discussed in a CIBC report. read more >

Silver: The HARD Look

Contributed Opinion
  ()
Precious metals expert Michael Ballanger takes a look at the factors behind silver's recent price decline. read more >

Avid Bioservices' Shares Rise on Q2/20 Earnings and Confirmed Outlook

  ()
Shares of Avid Bioservices traded higher, reaching a new 52-week high, after the firm reported Q2/20 earnings and reaffirmed its revenue guidance for Full-Year 2020. read more >
News Update

Oil & Gas Firm Provides Update on Exploration Well

News Update
  ()
Drill testing leads to decision to abandon the well. read more >
News Update

Company Extends REE Mineralization at Canada Project

News Update
  ()
Consequently, additional drill testing is warranted in the specific host zone. read more >

Analyst Believes Biopharma's Alzheimer's Treatment Could Be Superior to Biogen's

Research Report
  ()
How this company's Alzheimer's therapeutic compares to an advanced-stage competitor is outlined in a Dawson James Securities note. read more >

ArQule Shares Double on Proposed $2.7 Billion Tender Offer from Merck

  ()
ArQule Inc. shares traded more than 100% higher after the company entered into definitive agreement to be acquired by a Merck subsidiary company for $20 per share. The deal is valued at $2.7 billion and is expected to close in the early part of Q1/20. read more >
News Update

Copper Company Closes 30% Share of Acquisition of Copper North Mining

News Update
  ()
The two companies are advancing adjoining projects in the Yukon. read more >
Showing Results: 1 to 25 of 806 Next

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts

"ELY should still have a very healthy treasury."
– Thibaut Lepouttre, Caesars Report
"LIO shouldn't lack for news flow in the new year."
– Brien Lundin, Gold Newsletter (Jefferson Financial)
"POE's Q3/19 results were in line with our forecasts."
– Bill Newman, Mackie Research Capital